Vernal Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vernal Biosciences, Inc. - overview
Established
2020
Location
Burlington, VT, US
Primary Industry
Biotechnology
About
Founded in 2020 and based in Vermont, US, Vernal Biosciences, Inc. operates as a manufacturer of mRNA and LNP-mRNA, platform process development technologies on a transactional basis. In June 2023, Vernal Biosciences, Inc. raised USD 20 million in venture funding co-led by Ampersand Capital Partners and Charles River Laboratories, with participation from Dynamk Capital and Vermont Center for Emerging Technologies.
As of 2023, the company is led by CEO, Christian Cobaugh. Vernal Biosciences' services and products include mRNA sequence design, custom mRNA, GMP mRNA manufacturing, LPN formulated mRNA, and catalog mRNA products such as reporter gene mRNA, genome editing mRNA, gene replacement mRNA, and antigen mRNA. The company plans to use the June 2023 funding to finish the construction of its GMP factory, support expanded mRNA and LNP manufacturing, and increase its capabilities to support cGMP manufacturing.
Current Investors
Ampersand, Charles River Laboratories, Dynamk Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Pharmaceutical Research & Development
Website
www.vernal.bio
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.